Studies of combination 6-mercaptopurine (NSC-755) and 6-methylmercaptopurine riboside (NSC-40774) in patients with acute leukemia and metastatic cancer.
D000208:Acute Disease; D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D007938:Leukemia / Q000188:drug therapy*; D008297:Male; D015122:Mercaptopurine / Q000008:administration & dosage* / Q000009:adverse effects; D008745:Methylation; D008875:Middle Aged; D009362:Neoplasm Metastasis / Q000188:drug therapy; D012266:Ribose
D012266:Ribose; D015122:Mercaptopurine